Nortech Systems Inc: Form 10-Q for the period ended Sep 30, 2019
Filed with the SEC on Nov 12, 2019 and accepted by EDGAR at Nov 12, 2019, 16:11 ET.
Management's discussion and analysis
As filed, 15,864 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Overview
We are a Maple Grove, Minnesota based full-service electronics manufacturing services (“EMS”) contract manufacturer of wire and cable assemblies, printed circuit board assemblies, higher-level assemblies and box builds for a wide range of industries. We provide value added engineering services and technical support including design, testing, prototyping and supply chain management to customers mainly in the aerospace and defense, medical, and industrial equipment markets. We maintain facilities in Bemidji, Blue Earth, Eden Prairie, Mankato, Merrifield, and Milaca, Minnesota; Monterrey, Mexico; and Suzhou, China. All of our facilities are certified to one or more of the ISO/AS standards, including 9001, AS9100 and 13485, with most having additional certifications based on the needs of the customers they serve.
Results of Operations
The following table presents statements of operations data as percentages of total net sales for the periods indicated:
| Three Months Ended September 30, 2019 | 2018 | Nine Months Ended September 30, 2019 | 2018 | |
|---|---|---|---|---|
| Net Sales | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of Goods Sold | 87.9 | 88.5 | 89.6 | 87.9 |
| Gross Profit | 12.1 | 11.5 | 10.4 | 12.1 |
| Selling Expenses | 2.0 | 2.4 | 2.5 | 3.3 |
| General and Administrative Expenses | 7.7 | 6.8 | 8.6 | 7.3 |
| Income from Operations | 2.4 | 2.3 | (0.7) | 1.5 |
| Other Expenses | (0.9) | (0.7) | (0.9) | (0.7) |
| Income (Loss) Before Income Taxes | 1.5 | 1.6 | (1.6) | 0.8 |
| Income Tax Expense | 0.1 | 0.4 | 0.2 | 0.4 |
| Net Income (Loss) | 1.4% | 1.2% | (1.8%) | 0.4% |
Net Sales
Net sales were $30.1 million in the third quarter of 2019, as compared to $29.6 million in the third quarter of the prior year, an increase of $0.5 million or 1.7%. Net sales results were varied by markets; the medical market increased by $2.7 million or 19.3% with medical devices accounting for the increase. The industrial market decreased by $2.5 million or 22.3% of sales in the third quarter of 2019 as compared to the same quarter of 2018. Net sales from the aerospace and defense markets increased by $0.2 million or 5.0% of sales in the third quarter of 2019 as compared to the third quarter of 2018.
Net sales were $85.5 million in the nine months ended 2019, as compared to $84.5 million in the prior year, an increase of $1.0 million or 1.1%. Net sales results were varied by markets; the medical market increased by 9.1 million, or 24.9% with medical device accounting for 84.5% of the increase and medical component products the remaining 15.5%. The industrial market decreased by $8.0 million of sales or 23.3% for the nine months ended September 30, 2019 as compared to the same period of 2018. Net sales from aerospace and defense markets remained flat in the nine months ended September 30, 2019 as compared to the same period of 2018.
Net sales by our major EMS industry markets for the three and nine months ended September 30, 2019 and 2018 were as follows (in thousands):
| Three months Ended September 30, 2019 $ | 2018 $ | % Change | Nine Months Ended September 30, 2019 $ | 2018 $ | % Change | |
|---|---|---|---|---|---|---|
| Medical | 17,043 | 14,280 | 19.3 | 46,006 | 36,838 | 24.9 |
| Industrial | 8,623 | 11,094 | (22.3) | 26,290 | 34,261 | (23.3) |
| Aerospace and Defense | 4,392 | 4,184 | 5.0 | 13,219 | 13,444 | (1.7) |
| Total Net Sales | 30,058 | 29,558 | 1.7 | 85,515 | 84,543 | 1.1 |
Net sales by timing of transfer of goods and services for the three and nine months ended September 30, 2019 is as follows (in thousands):
| Three Months Ended September 30, 2019 Product/ Service Transferred Over Time | Product Transferred at Point in Time | Noncash Consideration | Total Net Sales by Market | |
|---|---|---|---|---|
| Medical | $14,399 | $1,661 | $983 | $17,043 |
| Industrial | 7,279 | 822 | 522 | 8,623 |
| Aerospace and Defense | 3,978 | 133 | 281 | 4,392 |
| Total net sales | $25,656 | $2,616 | $1,786 | $30,058 |
| Nine Months Ended September 30, 2019 Product/ Service Transferred Over Time | Product Transferred at Point in Time | Noncash Consideration | Total Net Sales by Market | |
|---|---|---|---|---|
| Medical | $42,039 | $1,914 | $2,053 | $46,006 |
| Industrial | 22,847 | 2,297 | 1,146 | 26,290 |
| Aerospace and Defense | 12,236 | 375 | 608 | 13,219 |
| Total net sales | $77,122 | $4,586 | $3,807 | $85,515 |
19
Net sales by timing of transfer of goods and services for the three and nine months ended September 30, 2018 is as follows (in thousands):
| Three Months Ended September 30, 2018 Product/ Service Transferred Over Time | Product Transferred at Point in Time | Noncash Consideration | Total Net Sales by Market | |
|---|---|---|---|---|
| Medical | $13,461 | $151 | $668 | $14,280 |
| Industrial | 9,486 | 1,116 | 492 | 11,094 |
| Aerospace and Defense | 3,931 | 50 | 203 | 4,184 |
| Total net sales | $26,878 | $1,317 | $1,363 | $29,558 |
| Nine Months Ended September 30, 2018 Product/ Service Transferred Over Time | Product Transferred at Point in Time | Noncash Consideration | Total Net Sales by Market | |
|---|---|---|---|---|
| Medical | $34,513 | $720 | $1,605 | $36,838 |
| Industrial | 29,698 | 3,165 | 1,398 | 34,261 |
| Aerospace and Defense | 12,675 | 170 | 599 | 13,444 |
| Total net sales | $76,886 | $4,055 | $3,602 | $84,543 |
Backlog
Our 90-day shipment backlog as of September 30, 2019 was $32 million, a 2.0% increase from the beginning of the quarter and a 15.6% increase from the prior year. Backlog for our medical customers has increased 6.4% from the beginning of the quarter and increased 37.8% from the prior year. Our industrial customers’ backlog increased 6.0% from the beginning of the quarter and decreased 10.2% from the prior year. The aerospace and defense backlog decreased 13.5% from the beginning of the quarter and increased 6.9% from the prior year. Our backlog consists of firm purchase orders we expect to ship in the next 90 days, with any remaining amounts to be transferred within 180 days.
90-day shipment backlog by our major EMS industry markets are as follows (in thousands):
| Shipment Backlog as of the Period Ended September 30, 2019 | June 30, 2019 | September 30, 2018 | |
|---|---|---|---|
| Medical | $17,778 | $16,701 | $12,902 |
| Industrial | 8,334 | 7,863 | 9,279 |
| Aerospace and Defense | 5,909 | 6,833 | 5,530 |
| Total 90-Day Backlog | $32,021 | $31,397 | $27,711 |
Our 90-day backlog varies due to order size, manufacturing delays, contract terms and conditions and timing from customer delivery schedules and releases. These variables cause inconsistencies in comparing the backlog from one period to the next. Our total shipment backlog was $58.1 million at September 30, 2019 compared to $43.1 million at the end of September 30, 2018.
Gross Profit
Gross profit as a percent of net sales for the three months ended September 30, 2019 and 2018 was 12.1% and 11.5%, respectively, driven by favorable product mix. Gross profit as a percentage of sales for the nine months ended September 30, 2019 and 2018 was 10.4% and 12.1%, respectively. The decline in gross profit in the year to date comparison was driven by product mix and operational inefficiencies due to component shortages.
Selling Expense
Selling expenses for the three months ended September 30, 2019 and 2018 was $0.6 million or 2.0% of sales and $0.7 million or 2.4% of sales, respectively. Selling expense for the nine months ended September 30, 2019 and 2018 was $2.1 million or 2.5% of sales and $2.8 million or 3.3% of sales, respectively. The decrease in both the three and nine month periods is due to lower sales incentives and timing of events.
General and Administrative Expense
General and administrative expenses for the three months ended September 30, 2019 and 2018 were $2.3 million or 7.7% of sales and $2.0 million or 6.8% of sales, respectively. General and administrative expenses for the nine months ended September 30, 2019 and 2018 were $7.4 million or 8.6% of sales and $6.2 million or 7.3% of sales, respectively. The increase in both comparisons was due to additional spend related to our recently implemented ERP system and one-time expenditures to improve operations.
Income (Loss) from Operations
Third quarter 2019 income from operations was $0.7 million compared to $0.6 million for the third quarter in 2018. Loss from operations for the first nine months in 2019 was $0.6 million as compared to income of $1.3 million for the same comparable period in 2018. The decrease to a loss from operations for the period was due to the gross profit decline and higher general and administrative expenses.
Income Taxes
On a quarterly basis, we estimate what our effective tax rate will be for the full fiscal year and record a quarterly income tax provision based on the anticipated rate. As the year progresses, we refine our estimate based on the facts and circumstances, including discrete events, by each tax jurisdiction. Our effective tax rate for the three and nine months ended September 30, 2019 was 10% and (9%) and the rate for the three and nine months ended September 30, 2018 was 24% and 49%, respectively.
Net Income (Loss)
Net income for the three months ended September 30, 2019 and September 30, 2018 was $0.4 million. Net loss for the nine months ended September 30, 2019 was $1.5 million and net income for the nine months ended September 30, 2018 was $0.4 million.
Liquidity and Capital Resources
Net cash used in operating activities for the nine months ended September 30, 2019 was $0.2 million. Net cash provided by operating activities for the nine months ended September 30, 2018 was $2.6 million driven by the net income net of the noncash adjustment of depreciation and amortization, along with an increase in accounts payable, partially offset by an increase in accounts receivable and inventories.
We have satisfied our liquidity needs over the past several years with cash flows generated from operations and a bank operating line of credit. We have a credit agreement with Bank of America (BofA) which was entered into on June 15, 2017 and amended on December 29, 2017 and provides for a line of credit arrangement of $16.0 million that expires on June 15, 2022. The credit arrangement also has a $5.0 million real estate term note outstanding with a maturity date of June 15, 2022.
Both the line of credit and real estate term notes are subject to fluctuations in the LIBOR rates. The line of credit and real estate term notes with BofA contain certain covenants which, among other things, require us to adhere to regular reporting requirements, abide by annual shareholder dividend limitations, maintain certain financial performance, and limit the amount of annual capital expenditures. The availability under our line is subject to borrowing base requirements, and advances are at the discretion of the lender. The line of credit is secured by substantially all of our assets.
On September 30, 2019, we had outstanding advances of $12.4 million under the line of credit and unused availability of $3.5 million supported by our borrowing base. We believe our financing arrangements and cash flows to be provided by operations will be sufficient to satisfy our future working capital needs. Our working capital was $22.7 million and $20.7 million as of September 30, 2019 and December 31, 2018, respectively.
The BofA credit agreement as amended provides for, among other things, a fixed charge coverage ratio of not less than (i) 1.0 to 1.0 for each period of four fiscal quarters, commencing with the period of four fiscal quarters ending December 31, 2018. As of September 30, 2019, we did not meet the fixed charge coverage ratio which was waived by BofA in the third amendment to the credit agreement received on November 8, 2019.
Off-Balance Sheet Arrangements
We have not engaged in any off-balance sheet activities as defined in Item 303(a)(4) of Regulation S-K.
Critical Accounting Policies and Estimates
Our significant accounting policies and estimates are summarized in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2018. Some of our accounting policies require us to exercise significant judgment in selecting the appropriate assumptions for calculating financial estimates. Such judgments are subject to an inherent degree of uncertainty. These judgments are based on our historical experience, known trends in our industry, terms of existing contracts and other information from outside sources, as appropriate. Actual results could differ from these estimates.
Forward-Looking Statements
Those statements in the foregoing report that are not historical facts are forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements generally will be accompanied by words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “possible,” “potential,” “predict,” “project,” or other similar words that convey the uncertainty of future events or outcomes. Although we believe these forward-looking statements are reasonable, they are based upon a number of assumptions concerning future conditions, any or all of which may ultimately prove to be inaccurate. Forward-looking statements involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation:
| ♦ | General economic, financial and business conditions that could affect our financial condition and results of operations; |
| ♦ | Volatility in the marketplace which may affect market supply and demand for our products or currency exchange rates; |
| ♦ | Increased competition from within the EMS industry or the decision of OEMs to cease or limit outsourcing; |
| ♦ | Changes in the reliability and efficiency of operating facilities or those of third parties; |
| ♦ | Risks related to availability of labor; |
| ♦ | Increase in certain raw material costs such as copper and oil; |
| ♦ | Commodity and energy cost instability; |
| ♦ | Risks related to quality, regulatory, securities laws and debt covenant noncompliance; |
| ♦ | Loss of a major customer or changes to customer orders; |
| ♦ | Increased or unanticipated costs related to compliance with securities and environmental regulation; and |
| ♦ | Disruption of global or local information management systems due to natural disaster or cyber-security incident. |
The factors identified above are believed to be important factors (but not necessarily all of the important factors) that could cause actual results to differ materially from those expressed in any forward-looking statement made by us. Discussion of these factors is also incorporated in Part I, Item 1A, “Risk Factors,” and should be considered an integral part of Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Unpredictable or unknown factors not discussed herein could also have material adverse effects on forward-looking statements. All forward-looking statements included in this Form 10-Q are expressly qualified in their entirety by the forgoing cautionary statements. We undertake no obligations to update publicly any forward-looking statement (or its associated cautionary language) whether as a result of new information or future events.
Please refer to forward-looking statements and risks as previously disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018.
Controls and procedures
As filed, 1,550 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
In accordance with Rule 13a-15(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this Quarterly Report on Form 10-Q, our management evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act). These controls and procedures are designed to ensure that information required to be disclosed in the Company’s Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to management, including the Company’s Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Based upon their evaluation of these disclosure controls and procedures as of the date of the evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective.
Changes in Internal Control Over Financial Reporting
Except for the implementation of certain internal controls related to the adoption of the new lease standard (ASC 842), there was no change in our internal control over financial reporting during our most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 627 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We are affected by the risks specific to us as well as factors that affect all businesses operating in a global market. The significant factors known to us that could materially adversely affect our business, financial condition or operating results or could cause our actual results to differ materially from our expectations are described in our annual report on Form 10-K for the fiscal year ended under the heading “Part I – Item 1A.Risk Factors.” Other than as noted below, there have been no material changes in the risk factors from those disclosed in the Annual Report on Form 10-K for the year ended December 31, 2018.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-07-01 to 2019-09-30 | $30.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2019-01-01 to 2019-09-30 | $85.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2019-07-01 to 2019-09-30 | $26.4m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2019-01-01 to 2019-09-30 | $76.6m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2019-07-01 to 2019-09-30 | $3.6m | us-gaap:GrossProfit |
| Gross profit | 9 months2019-01-01 to 2019-09-30 | $8.9m | us-gaap:GrossProfit |
| Operating income | 3 months2019-07-01 to 2019-09-30 | $713.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2019-01-01 to 2019-09-30 | −$600.0k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2019-07-01 to 2019-09-30 | $256.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2019-01-01 to 2019-09-30 | $780.0k | us-gaap:InterestExpense |
| Income tax | 3 months2019-07-01 to 2019-09-30 | $44.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2019-01-01 to 2019-09-30 | $122.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-07-01 to 2019-09-30 | $413.0k | us-gaap:NetIncomeLoss |
| Net income | 9 months2019-01-01 to 2019-09-30 | −$1.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-07-01 to 2019-09-30 | $0.16 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2019-01-01 to 2019-09-30 | −$0.56 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-07-01 to 2019-09-30 | $0.16 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2019-01-01 to 2019-09-30 | −$0.56 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-07-01 to 2019-09-30 | 2,657,911 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2019-01-01 to 2019-09-30 | 2,667,754 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2019-01-01 to 2019-09-30 | −$233.0k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2019-01-01 to 2019-09-30 | $785.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2019-01-01 to 2019-09-30 | $130.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-09-30 | $160.0k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-09-30 | $48.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2019-09-30 | $66.8m | us-gaap:Assets |
| Current liabilities | At period end2019-09-30 | $25.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-09-30 | $47.1m | us-gaap:Liabilities |
| Long-term debt | At period end2019-09-30 | $3.3m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2019-09-30 | $444.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2019-09-30 | $19.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-19-022464. Last ingested by Listed: Nov 12, 2026, 19:20 ET. Listed shows no prices and gives no investment advice.